Sartorius Stedim Biotech ... (SDMHF)
PNK: SDMHF
· Real-Time Price · USD
216.65
-3.35 (-1.52%)
At close: May 30, 2025, 3:33 PM
Sartorius Stedim Biotech S.A. Balance Sheet Statement
Financials in EUR. Fiscal
year is
January - December.
Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 707.6M | 678.9M | 482.6M | 454.1M | 695.1M | 116.6M | 99.3M | 110M | 94M | 107.1M | 145.5M | 156.1M | 165.1M | 223.63M | 226.8M | 254.7M | 149.4M |
Short-Term Investments | 19.4M | 9.9M | 18.2M | n/a | 32.6M | 9.5M | 19.4M | 14.3M | 19M | 25.9M | 16.2M | 24.9M | 47.1M | 13.72M | 9.7M | n/a | 15.2M |
Long-Term Investments | 4.3M | 14.1M | 16.9M | 36.7M | 41M | 40.8M | 18.7M | 10M | 5.6M | -1M | -800K | -9.9M | -32.2M | 1.05M | 4.7M | 14.9M | -1.3M |
Other Long-Term Assets | 24.2M | 13.5M | 19.9M | 2.5M | 2.5M | 2.7M | 21.8M | 17.1M | 21.4M | 28.1M | 16.9M | 25.5M | 47.7M | 14.38M | 10.2M | 600K | 15.7M |
Receivables | 267M | n/a | n/a | 297.5M | 332.8M | n/a | 305.8M | 323.8M | 362M | 404.6M | 446.5M | 439.9M | 408.7M | n/a | 358.1M | 307.9M | 308.2M |
Inventory | 683.5M | 684.9M | 745.7M | 797.1M | 872.7M | 882.4M | 992M | 1.03B | 1.06B | 1.02B | 1.06B | 964.1M | 857.5M | 782.95M | 703.9M | 599.6M | 534.8M |
Other Current Assets | 102.5M | 367.3M | 374M | 148.9M | 177M | 112.9M | 108.5M | 127.6M | 110.3M | 109.9M | 114.1M | 112.1M | 84.9M | 80.3M | 99M | 89.8M | 69.4M |
Total Current Assets | 1.78B | 1.74B | 1.62B | 1.7B | 2.08B | 1.42B | 1.52B | 1.62B | 1.65B | 1.67B | 1.78B | 1.7B | 1.56B | 1.46B | 1.39B | 1.25B | 1.06B |
Property-Plant & Equipment | 1.93B | 1.89B | 1.75B | 1.72B | 1.68B | 1.63B | 1.56B | 1.46B | 1.36B | 1.29B | 1.19B | 1.07B | 986.6M | 928.41M | 799.8M | 726M | 693.8M |
Goodwill & Intangibles | 4.5B | 4.54B | 4.54B | 4.56B | 4.58B | 4.59B | 4.77B | 2.03B | 2.01B | 2.01B | 2.04B | 1.54B | 1.54B | 1.51B | 1.74B | 1.5B | 1.51B |
Total Long-Term Assets | 6.52B | 6.52B | 6.38B | 6.37B | 6.36B | 6.34B | 6.43B | 3.57B | 3.45B | 3.39B | 3.32B | 2.68B | 2.6B | 2.5B | 2.59B | 2.27B | 2.25B |
Total Assets | 8.3B | 8.26B | 8B | 8.07B | 8.44B | 7.75B | 7.96B | 5.19B | 5.1B | 5.07B | 5.1B | 4.38B | 4.16B | 3.95B | 3.98B | 3.52B | 3.31B |
Account Payables | 317M | 310M | 192.8M | 203.2M | 402.8M | 258.5M | 412.1M | 440.4M | 454.9M | 251.5M | 520.3M | 520.8M | 506M | 251.3M | 439.8M | 407.4M | 364.6M |
Deferred Revenue | n/a | n/a | n/a | 199.9M | 133.6M | 189.4M | 313.9M | 360.5M | 393.6M | 663.1M | 510.7M | 403.2M | 376.7M | 660.2M | 362.8M | 275.1M | 230.1M |
Short-Term Debt | 69M | 39.6M | 8.4M | 130.2M | 88.3M | 57.7M | 11.9M | 7M | 174.9M | 4.5M | 57.4M | 130.7M | 27.7M | 25.5M | 50.6M | 26.4M | 27.6M |
Other Current Liabilities | 470.2M | 441M | 394.6M | 242.5M | 394.4M | 537.4M | 2.6M | 13M | 17.1M | 686.3M | 493.7M | 412.5M | 18.9M | 580.42M | 322.7M | 258.8M | 10.4M |
Total Current Liabilities | 964.7M | 938.8M | 757.9M | 873.8M | 975.4M | 937.3M | 853.6M | 922M | 1.15B | 1.04B | 1.19B | 1.16B | 1.03B | 1.04B | 938.6M | 792.4M | 708M |
Long-Term Debt | 2.68B | 2.68B | 2.68B | 2.68B | 2.98B | 3.51B | 3.66B | 1.24B | 1.02B | 1.02B | 1.02B | 521.1M | 521.3M | 521.1M | 522.5M | 515.4M | 515.4M |
Other Long-Term Liabilities | 129.9M | 130.6M | 125.7M | 503.9M | 126.2M | 138.5M | 565.4M | 330.9M | 100K | 100K | 306M | 503.5M | 546.6M | 469.85M | 694.8M | 94.1M | 479.9M |
Total Long-Term Liabilities | 3.33B | 3.29B | 3.3B | 3.27B | 3.6B | 4.14B | 4.48B | 1.66B | 1.49B | 1.52B | 1.56B | 1.09B | 1.13B | 1.18B | 1.27B | 1.04B | 1.05B |
Total Liabilities | 4.3B | 4.23B | 4.06B | 4.14B | 4.57B | 5.08B | 5.33B | 2.58B | 2.64B | 2.55B | 2.75B | 2.25B | 2.16B | 2.22B | 2.21B | 1.83B | 1.76B |
Total Debt | 2.93B | 2.87B | 2.83B | 2.92B | 3.19B | 3.68B | 3.79B | 1.36B | 1.31B | 1.14B | 1.17B | 732.2M | 630.9M | 625.52M | 643.1M | 609.9M | 609.2M |
Common Stock | 19.5M | 19.5M | 19.5M | 19.5M | 19.5M | 18.4M | 18.4M | 18.4M | 18.4M | 18.4M | 18.4M | 18.4M | 18.4M | 18.44M | 18.4M | 18.4M | 18.4M |
Retained Earnings | 2.53B | 2.54B | 2.46B | 2.43B | 2.39B | 2.39B | 2.34B | 2.3B | 2.17B | 2.18B | 2.02B | 1.8B | 1.67B | 1.41B | 1.42B | 1.42B | 1.28B |
Comprehensive Income | n/a | n/a | n/a | 1.44B | 1.42B | 228.9M | 231.5M | 231.6M | 231.5M | 251.9M | 231.5M | 282.4M | 231.6M | 251.81M | 231.5M | 223.9M | 231.6M |
Shareholders Equity | 3.97B | 3.99B | 3.9B | 3.89B | 3.83B | 2.64B | 2.59B | 2.57B | 2.42B | 2.45B | 2.27B | 2.05B | 1.92B | 1.66B | 1.67B | 1.67B | 1.53B |
Total Investments | 23.7M | 24M | 35.1M | 36.7M | 41M | 40.8M | 38.1M | 24.3M | 24.6M | 24.9M | 15.4M | 15M | 14.9M | 14.77M | 14.4M | 14.9M | 13.9M |